RIMKLA Antikörper (AA 19-391) (APC)
Kurzübersicht für RIMKLA Antikörper (AA 19-391) (APC) (ABIN8032521)
Target
Alle RIMKLA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 19-391
-
Verwendungszweck
- Anti-RIMKLA Antibody APC Conjugated
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human RIMKLA recombinant protein (Position: Q19-K391).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Haltbarkeit
- 12 months
-
-
- RIMKLA (Ribosomal Modification Protein RimK-Like Family Member A (RIMKLA))
-
Andere Bezeichnung
- RIMKLA
-
Hintergrund
-
Background: Predicted to enable N-acetyl-L-aspartate-L-glutamate ligase activity. Predicted to be involved in glutamine family amino acid metabolic process. Predicted to be located in cytosol. Predicted to be active in cytoplasm.
Gene Full Name: ribosomal modification protein rimK like family member A
-
Gen-ID
- 284716
-
UniProt
- Q8IXN7
Target
-